Form 4: SuRo Capital Director Ronald Lott Receives Significant Restricted Stock Grant

SuRo Capital Corp. Director Ronald M. Lott was granted 7,812 shares of common stock as restricted stock, vesting on the earlier of May 28, 2026, or the company's annual meeting closest to that date.

Summary

• Ronald M. Lott, a Director of SuRo Capital Corp. (SSSS), acquired 7,812 shares of common stock on May 28, 2025.
• The acquisition was a grant of restricted shares under the SuRo Capital Corp. Second Amended and Restated 2019 Equity Incentive Plan, with a transaction price of $0 per share.
• Following this transaction, Mr. Lott beneficially owns a total of 37,123 shares of common stock.
• These restricted shares are set to vest in full on the earlier of May 28, 2026, or the date of SuRo Capital Corp.'s annual meeting of stockholders that is closest to the first anniversary of the award date.

Sentiment

Score: 7

Explanation: The grant of restricted stock to a director is generally a positive sign of alignment between management and shareholder interests, and a routine compensation practice. It does not indicate any immediate negative operational or financial issues for the company.

Positives

• The grant of restricted shares to Director Ronald M. Lott aligns his interests with long-term shareholder value, as the shares vest over time.
• The transaction indicates the company's continued use of its 2019 Equity Incentive Plan to compensate and incentivize key personnel, which is a common corporate governance practice.

Risks

• The ultimate value of the granted shares to Director Lott is contingent on the future performance of SuRo Capital Corp.'s stock price until the vesting date.

Future Outlook

The vesting schedule of the restricted shares indicates a future milestone for the compensation of Director Lott, aligning his incentives with the company's performance through at least May 2026.

Industry Context

Restricted stock grants are a standard practice in corporate compensation across various industries, particularly in investment firms like SuRo Capital Corp., to retain and incentivize directors and executives by linking their compensation to the company's long-term performance and strategic objectives.

Comparison to Industry Standards

• The use of restricted stock grants is a common compensation mechanism for directors in the financial services industry, similar to practices at other publicly traded investment companies or Business Development Companies (BDCs) like Ares Capital Corporation (ARCC) or Prospect Capital Corporation (PSEC), which frequently utilize equity-based incentives to align management interests with shareholders.
• The specified vesting period, while not unusually long, is typical for director grants, ensuring continued engagement and oversight over a reasonable timeframe.

Corporate Governance

Stakeholder Impact

• Shareholders: Potential positive impact due to increased alignment of the director's interests with the company's long-term performance and value creation.
• Employees: No direct impact mentioned, but reflects a standard compensation practice that could apply to other key personnel within the organization.

Next Steps

• Monitoring the vesting of the 7,812 restricted shares on or around May 28, 2026, or the date of the closest annual meeting, which will impact Director Lott's beneficial ownership.

Key Dates

Recommendation

Keywords

SuRo Capital Corp., SSSS, Form 4, Insider Transaction, Restricted Stock, Equity Incentive Plan, Director Compensation, Stock Grant